Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Hair loss can occur when stomach cancer spreads to the scalp.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Finasteride slows down motherly behavior in first-time pregnant rats.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.